A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
Clinical trial NCT07748208 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748208
- Sponsor
- Hoffmann-La Roche
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-06-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.